[
  {
    "ts": null,
    "headline": "Health Care Stocks Climb on Rate Cute Hopes -- Health Care Roundup",
    "summary": "Health Care Stocks Climb on Rate Cute Hopes -- Health Care Roundup",
    "url": "https://finnhub.io/api/news?id=6d36b273c0241e46a0b057539b2e0de0c0ee2a157ec4dceef90de40e22192955",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754328780,
      "headline": "Health Care Stocks Climb on Rate Cute Hopes -- Health Care Roundup",
      "id": 136208642,
      "image": "",
      "related": "JNJ",
      "source": "MarketWatch",
      "summary": "Health Care Stocks Climb on Rate Cute Hopes -- Health Care Roundup",
      "url": "https://finnhub.io/api/news?id=6d36b273c0241e46a0b057539b2e0de0c0ee2a157ec4dceef90de40e22192955"
    }
  },
  {
    "ts": null,
    "headline": "Why Johnson & Johnson Stock Still Has Room To Run",
    "summary": "Johnson & Johnson's stock still has room to rise after the recent financial results exceeded expectations. Learn how J&J is positioned for success.",
    "url": "https://finnhub.io/api/news?id=f91fa708d468ed0055cf208a7e499c4baab6bc95d328e2fd9c2318d48af28388",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754327543,
      "headline": "Why Johnson & Johnson Stock Still Has Room To Run",
      "id": 136202830,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/505129430/image_505129430.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson's stock still has room to rise after the recent financial results exceeded expectations. Learn how J&J is positioned for success.",
      "url": "https://finnhub.io/api/news?id=f91fa708d468ed0055cf208a7e499c4baab6bc95d328e2fd9c2318d48af28388"
    }
  },
  {
    "ts": null,
    "headline": "Jessica Dean Named Finalist for Texas Legal Awards’ 2025 Influential Woman of the Year",
    "summary": "DALLAS, August 04, 2025--National plaintiff firm Dean Omar Branham Shirley, LLP, is pleased to announce that name partner Jessica Dean has been named a Texas Legal Awards finalist for Influential Woman of the Year by Texas Lawyer and Law.com. The winner will be announced in late September.",
    "url": "https://finnhub.io/api/news?id=f92ef1ae1a2d2eac892056851dabd20a43c9e3106c7fd05dc82b3efa20da40a8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754322720,
      "headline": "Jessica Dean Named Finalist for Texas Legal Awards’ 2025 Influential Woman of the Year",
      "id": 136200249,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "DALLAS, August 04, 2025--National plaintiff firm Dean Omar Branham Shirley, LLP, is pleased to announce that name partner Jessica Dean has been named a Texas Legal Awards finalist for Influential Woman of the Year by Texas Lawyer and Law.com. The winner will be announced in late September.",
      "url": "https://finnhub.io/api/news?id=f92ef1ae1a2d2eac892056851dabd20a43c9e3106c7fd05dc82b3efa20da40a8"
    }
  },
  {
    "ts": null,
    "headline": "Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?",
    "summary": "Let's look at five pharma and biotech companies, PFE, LLY, AMGN, GILD and NVO, which are scheduled to release their second-quarter 2025 results this week.",
    "url": "https://finnhub.io/api/news?id=883190f0e2f70a7ee2c2c89d4029b1a0d3a68266fb7467a0b0963edd4dee601a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754322480,
      "headline": "Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?",
      "id": 136200228,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Let's look at five pharma and biotech companies, PFE, LLY, AMGN, GILD and NVO, which are scheduled to release their second-quarter 2025 results this week.",
      "url": "https://finnhub.io/api/news?id=883190f0e2f70a7ee2c2c89d4029b1a0d3a68266fb7467a0b0963edd4dee601a"
    }
  },
  {
    "ts": null,
    "headline": "J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?",
    "summary": "JNJ lifts 2025 sales and EPS outlook on strong Q2 results, with new drug launches and MedTech gains fueling momentum.",
    "url": "https://finnhub.io/api/news?id=bd652f35b7613020e47289169149141281db27be04e3b917412a54cdce6f0f38",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754311860,
      "headline": "J&J Expects Better Top-Line Growth in 2H: Can It Achieve the Goal?",
      "id": 136200252,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "JNJ lifts 2025 sales and EPS outlook on strong Q2 results, with new drug launches and MedTech gains fueling momentum.",
      "url": "https://finnhub.io/api/news?id=bd652f35b7613020e47289169149141281db27be04e3b917412a54cdce6f0f38"
    }
  },
  {
    "ts": null,
    "headline": "How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?",
    "summary": "AbbVie's Q2 results show Skyrizi and Rinvoq powering growth, offsetting Humira declines and lifting 2025 sales outlook.",
    "url": "https://finnhub.io/api/news?id=9c132eec1758bc3561b9be905e163bf9acfd270aee745dd8f37eab5499c6e846",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754309700,
      "headline": "How Did Skyrizi and Rinvoq Sales Contribute to AbbVie's Q2 Results?",
      "id": 136200231,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "AbbVie's Q2 results show Skyrizi and Rinvoq powering growth, offsetting Humira declines and lifting 2025 sales outlook.",
      "url": "https://finnhub.io/api/news?id=9c132eec1758bc3561b9be905e163bf9acfd270aee745dd8f37eab5499c6e846"
    }
  },
  {
    "ts": null,
    "headline": "Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement",
    "summary": "WAYNE, Pa. & NEW YORK, August 04, 2025--Sam Brown Healthcare Communications, a Blue Matter Company, is proud to announce the appointment of Michael Heinley to the new position of Managing Director, Client Development and Engagement, reporting to Founder and President Laura Liotta.",
    "url": "https://finnhub.io/api/news?id=9b15d5a944d25a5748d7dc08ea573680198b00a8e293d1b03cd6172b6781b55a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754307000,
      "headline": "Michael Heinley Joins Sam Brown Healthcare Communications As Managing Director, Client Development and Engagement",
      "id": 136197862,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "WAYNE, Pa. & NEW YORK, August 04, 2025--Sam Brown Healthcare Communications, a Blue Matter Company, is proud to announce the appointment of Michael Heinley to the new position of Managing Director, Client Development and Engagement, reporting to Founder and President Laura Liotta.",
      "url": "https://finnhub.io/api/news?id=9b15d5a944d25a5748d7dc08ea573680198b00a8e293d1b03cd6172b6781b55a"
    }
  },
  {
    "ts": null,
    "headline": "Why Johnson & Johnson Could Be a Safe Long-Term Bet for Your Portfolio?",
    "summary": "J&J is posting good growth and is available at fair valuations.",
    "url": "https://finnhub.io/api/news?id=cb17bf2b37ad4a3deb9e89c81c77df9a9d6cc8bfe6acbfd5ed597ca0de205cc5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754301606,
      "headline": "Why Johnson & Johnson Could Be a Safe Long-Term Bet for Your Portfolio?",
      "id": 136197863,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "J&J is posting good growth and is available at fair valuations.",
      "url": "https://finnhub.io/api/news?id=cb17bf2b37ad4a3deb9e89c81c77df9a9d6cc8bfe6acbfd5ed597ca0de205cc5"
    }
  },
  {
    "ts": null,
    "headline": "The Zacks Analyst Blog Highlights Adobe, Disney, Intuit, Rollins and Johnson & Johnson",
    "summary": "Adobe, Disney, Intuit, Rollins, and Johnson & Johnson earn \"wide moat\" praise for durable growth, innovation, and market resilience.",
    "url": "https://finnhub.io/api/news?id=762c94823ad9b18144f3dbf88023741f382a5eaf3910b686ba068598cc3b23bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754299560,
      "headline": "The Zacks Analyst Blog Highlights Adobe, Disney, Intuit, Rollins and Johnson & Johnson",
      "id": 136197864,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Adobe, Disney, Intuit, Rollins, and Johnson & Johnson earn \"wide moat\" praise for durable growth, innovation, and market resilience.",
      "url": "https://finnhub.io/api/news?id=762c94823ad9b18144f3dbf88023741f382a5eaf3910b686ba068598cc3b23bb"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare",
    "summary": "CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.",
    "url": "https://finnhub.io/api/news?id=9712ee381ad80a17d1634e5f229bcc7f96e971f0fb79426b7a14e371833904f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754298060,
      "headline": "Zacks Investment Ideas feature highlights: CVS Health, Johnson & Johnson and Tenet Healthcare",
      "id": 136197866,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "CVS, JNJ, and Tenet Healthcare shine as defensive picks with strong earnings momentum and attractive valuations.",
      "url": "https://finnhub.io/api/news?id=9712ee381ad80a17d1634e5f229bcc7f96e971f0fb79426b7a14e371833904f1"
    }
  },
  {
    "ts": null,
    "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
    "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
    "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754288400,
      "headline": "Janus Henderson Global Life Sciences Fund Q2 2025 Commentary",
      "id": 136196996,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/172204552/image_172204552.jpg?io=getty-c-w1536",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "Janus Henderson reviews Q2 healthcare headwinds and standout biotech picks. Learn how the fund is navigating policy shifts and finding innovation upside.",
      "url": "https://finnhub.io/api/news?id=0b87039d99d7e9cf0a9a88ab06e6861b276113fa4e554693cfbacf40d7eb67b3"
    }
  },
  {
    "ts": null,
    "headline": "Tweedy, Browne Mutual Funds Q2 2025 Commentary",
    "summary": "Tweedy, Browne Mutual Funds Q2 2025 Commentary",
    "url": "https://finnhub.io/api/news?id=3cf7e2c3130a95f7560c4fd3df60a857256a8bf8c80df0fabd261a098f21ca7b",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754274000,
      "headline": "Tweedy, Browne Mutual Funds Q2 2025 Commentary",
      "id": 136196176,
      "image": "",
      "related": "JNJ",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=3cf7e2c3130a95f7560c4fd3df60a857256a8bf8c80df0fabd261a098f21ca7b"
    }
  }
]